9 completed. 9 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 3 | Completed 3 |
Follow Panic Disorder: new trials by email Literature Review of Panic Disorder trials Research Report on Panic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects CVL-865 High dose, Alprazolam 1mg XR, Placebo - Panic Disorder | Phase 1 | Completed | Cerevel Therapeutics, LLC | 56 | 2020-10-06 | 2022-01-11 |
| Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers Paroxetine Hydrochloride Tablet 20 mg, Paxil® 20 mg - Major Depressive Disorder, Obsessive-Compulsive Disorder | Phase 1 | Completed | Beijing Tongren Hospital | 53 | 2018-03-29 | 2018-12-19 |
| The Modular Protocol for Mental Health (MPMH) The Modular Protocol for Mental Health, Treatment-as-usual - Major Depressive Disorder, Generalized Anxiety Disorder | Phase 1 / Phase 2 | Completed | Medical Research Council Cognition and Brain Sciences Unit | 43 | 2017-07-18 | 2020-09-29 |
| Bringing What Works to Youth in Corrections: A Trauma Intervention Trauma-Focused Cognitive Behavioral Therapy - Post-Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | University of Texas at Austin | 57 | 2012-11-01 | 2016-03-17 |
| Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1) Multiple Channel Exposure Therapy- Veterans - PTSD, Panic Attacks | Phase 1 | Completed | VA Office of Research and Development | 7 | 2012-03-01 | 2017-02-23 |
| Staccato Alprazolam Single Dose PK Alprazolam thermal aerosol - Healthy | Phase 1 | Completed | Alexza Pharmaceuticals, Inc. | 50 | 2005-06-01 | 2017-03-14 |
| Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ [18F] SPA-RQ - Panic Disorder, Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 84 | 2004-07-27 | 2017-07-02 |
| Therapy for Depression With Co-occurring Panic or Anxiety Symptoms Interpersonal Psychotherapy (IPT), IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS) - Depression, Anxiety Disorders | Phase 1 / Phase 2 | Completed | University of Pittsburgh | 36 | 2002-11-01 | 2013-06-25 |
| Interactive Computer Treatment for Panic Disorder Computer Based Cognitive Behavioral Therapy - Panic Disorder | Phase 1 | Completed | Florida State University | 60 | 2002-01-01 | 2021-11-04 |
Anxiety Disorders (3) · Depressive Disorder, Major (3) · Generalized Anxiety Disorder (3) · Phobia, Social (3) · Stress Disorders, Post-Traumatic (3) · Obsessive-Compulsive Disorder (2) · Agoraphobia (1) · Depression (1) · Dysthymic Disorder (1) · Hypercapnia (1) · Mood Disorders (1)
Mental Disorders (9) · Anxiety Disorders (6) · Depressive Disorder (3) · Mood Disorders (3) · Phobic Disorders (3) · Stress Disorders, Traumatic (3) · Trauma and Stressor Related Disorders (3) · Behavior (1) · Behavioral Symptoms (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
(2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine (1) · Alprazolam (1) · Interpersonal Psychotherapy (1) · Mental Health (1) · Paroxetine (1) · adenylate isopentenyltransferase (1)
Alexza Pharmaceuticals, Inc. (1) · Beijing Tongren Hospital (1) · Cerevel Therapeutics, LLC (1) · Florida State University (1) · Medical Research Council Cognition and Brain Sciences Unit (1) · National Institute of Mental Health (NIMH) (1) · University of Pittsburgh (1) · University of Texas at Austin (1) · VA Office of Research and Development (1)
United States (5) · China (1) · Netherlands (1) · United Kingdom (1)
Ellen Teng, PhD (1) · Gabriel Etienne Jacobs, PhD, MD (1) · Molly M Lopez, Ph.D. (1) · Randall Stoltz, MD (1) · Tim Dalgleish, PhD (1) · Xiuli Zhao, PhD (1)
R21MH062056 (1), R34MH095210 (1)